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Platelets are essential for wound healing and inﬂammatory
processes, but can also play a deleterious role by causing heart
attack and stroke. Normal platelet activation is dependent on
tetraspanins, a superfamily of glycoproteins that function as
‘organisers’ of cell membranes by recruiting other receptors
and signalling proteins into tetraspanin-enriched microdomains.
However, our understanding of how tetraspanin microdomains
regulate platelets is hindered by the fact that only four of the 33
mammalian tetraspanins have been identiﬁed in platelets. This is
because of a lack of antibodies tomost tetraspanins and difﬁculties
in measuring mRNA, due to low levels in this anucleate cell. To
identify potentially platelet-expressed tetraspanins, mRNA was
measured in their nucleated progenitor cell, the megakaryocyte,
using serial analysis of gene expression and DNA microarrays.
Amongst 19 tetraspanins identiﬁed in megakaryocytes, Tspan9,
a previously uncharacterized tetraspanin, was relatively speciﬁc
to these cells. Through generating the ﬁrst Tspan9 antibodies,
Tspan9 expression was found to be tightly regulated in platelets.
The relative levels of CD9, CD151, Tspan9 and CD63 were 100,
14, 6 and 2, respectively. Since CD9 was expressed at 49000 cell
surface copies per platelet, this suggested a copy number of 2800
Tspan9 molecules. Finally, Tspan9 was shown to be a component
of tetraspanin microdomains that included the collagen recep-
tor GPVI and integrin α6β1, but not the von Willebrand receptor
GPIbα or the integrins αIIbβ3 or α2β1. These ﬁndings suggest
a role for Tspan9 in regulating platelet function in concert with
other platelet tetraspanins and their associated proteins.
Key words: GPVI, megakaryocyte, membrane microdomain,
platelet, tetraspanin, Tspan9.
INTRODUCTION
Platelets play an essential role in preventing excessive blood loss
at sites of vascular injury by plugging holes in damaged blood
vessels and promoting the clotting cascade. Platelets are also
important in inﬂammation through recruitment of leukocytes,
and in blood vessel repair through the release of growth factors.
However, platelets also play a deleterious role in causing heart
attack and stroke when activated in diseased vessels [1]. Critical
to these events are a variety of well-characterized surface receptor
proteins which combine to induce powerful platelet activation
when they encounter exposed sub-endothelial matrix proteins in
the damaged vessel wall [2]. It is becoming increasingly clear that
such cell surface proteins and their associated signalling proteins
are not randomly distributed in the plasma membrane, but are
instead compartmentalized into membrane microdomains [3].
The tetraspanins are a large family of four-transmembrane
glycoproteins that are thought to function as ‘molecular org-
anizers’ by forming a type of membrane microdomain that is dis-
tinct from lipid rafts [4–6]. This is achieved through tetraspanin–
tetraspanin associations and speciﬁc tetraspanin interactions with
so-called partner proteins, which include integrins, immuno-
globulin superfamily proteins and G-protein-coupled receptors.
Such a fundamental organizing role is consistent with tetraspanin
expression throughout the fungi, plant and animal kingdoms and
their essential roles in processes such as cell adhesion, motility
and signal transduction [4].
An essential role for tetraspanins in platelets was demonstrated
by mild bleeding phenotypes in mice deﬁcient for either of the
tetraspanins CD151 or Tspan32 (previously named TSSC6 or
PHEMX) [7,8]. These similar phenotypes appear to be due to
impaired signalling by the major platelet integrin αIIbβ3, but
their weak nature suggests functional redundancy between tetra-
spanins. However, only two other tetraspanins, CD9 and CD63,
have been identiﬁed on platelets using antibodies [9]. Identi-
ﬁcation of other platelet tetraspanins is impaired by a lack of
antibodies to most of the 33 mammalian tetraspanins. Addi-
tionally, the anucleate platelet has minimal mRNA levels [10],
which makes RT–PCR (reverse transcription–PCR) challenging
due to the issue of contamination with mRNA from other blood
cells.
The present study aimed to identify a novel platelet tetraspanin
through genomic analyses of megakaryocytes, the platelet pro-
genitors, and subsequent antibody generation to conﬁrm expres-
sion on platelets.
MATERIALS AND METHODS
Genomics
The SAGE (serial analysis of gene expression) library from
primary mouse megakaryocytes was generated using the I-
SAGE Long Kit (Invitrogen) as described previously [11]. SAGE
Abbreviations used: DIC, differential interference contrast; ECL, enhanced chemiluminescence; HEK-293T cells, HEK (human embryonic kidney)-293
cells expressing the large T-antigen of SV40 (simian virus 40); PNGase F, peptide N-glycosidase F; RT–PCR, reverse transcription–PCR; SAGE, serial
analysis of gene expression.
1 To whom correspondence should be addressed (email m.g.tomlinson@bham.ac.uk).
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tags were identiﬁed using SAGE2000 4.5 Analysis Software
(Invitrogen) and each tetraspanin tag was conﬁrmed manually
by referring to GenBank entries in the National Center for
Biotechnology Information public database. The HaemAtlas
microarray data was generated as described [12] from monocytes
(CD14+), B-cells (CD19+), helper T-cells (CD4+), natural killer
cells (CD56+), granulocytes (CD66b+) and cytotoxic T cells
(CD8+) isolated from seven human volunteers, and erythroblasts
and megakaryocytes differentiated from CD34+ haematopoietic
stem cells.
Cell culture
The HEK-293T [HEK (human embryonic kidney)-293 cells
expressing the large T-antigen of SV40 (simian virus 40)]
cell line was cultured in DMEM (Dulbecco’s modiﬁed Eagle’s
medium) supplemented with 10% fetal bovine serum, penicillin,
streptomycin, and glutamine. The DG75 and Raji human B-
cell lines, the HPB-ALL and Jurkat human T-cell lines, the
DAMI and MEG-01 human megakaryocyte-like cell lines, and
the HEL human erythroleukaemia line, were all cultured in
RPMI supplemented with 10% fetal bovine serum, penicillin,
streptomycin, and glutamine.
FLAG-tagged tetraspanin constructs
Tetraspanin cDNAs were generated by PCR from the following
sources: DAMI human megakaryocyte-like cell line cDNA for
CD9 and CD151; speciﬁc cDNA for CD63 [13]; and mouse
primary megakaryocyte cDNA for Tspan9 [11]. These were
cloned into the pEF6/Myc-His vector (Invitrogen) which had been
modiﬁed to include an in-frame, upstream sequence for the FLAG
epitope tag. The endogenous stop codons were retained for each
tetraspanin construct to prevent translation of the Myc and His
epitope tags.
Antibodies
The mouse negative control monoclonal antibody (MOPC 21)
and the rabbit anti-FLAG antibody were from Sigma, while
the normal rabbit control IgG was from Upstate. The mouse
monoclonal antibodies to human tetraspanins CD9 (C9-BB and
1AA2) [14,15], CD63 (6H1 and 12F12) [16,17] and CD151
(11B1) [15] and to human GPVI (204-11) [18] and GPIbα
(WM23) [19], were as described, whereas those to integrins αIIb
(SZ22), α2 (Gi9) and α6 (4F10) were from Beckman Coulter,
Immunotech and Serotec respectively.
Generation of Tspan9 polyclonal antibodies
A peptide with the sequence QHIHRTGKKYDA, corresponding
to the C-terminus of human and mouse Tspan9, conjugated to
keyhole limpet haemocyanin via an additionalN-terminal cysteine
residue, was used to immunize one rabbit and one chicken by
Eurogentec. IgY was puriﬁed from chicken yolks using the Pierce
Eggcellent Chicken IgY Puriﬁcation Kit (Perbio). Rabbit and
chicken anti-Tspan9 antibodies were then peptide-puriﬁed using
the Pierce SulfoLink Kit according to the manufacturer’s protocol
(Perbio).
Confocal microscopy
Fetal liver mouse megakaryocytes were prepared and cultured as
described [20], and mature megakaryocytes were collected after
ﬁve days by passing the culture over a bovine serum albumin
step gradient. Megakaryocytes were allowed to spread for two
hours on coverslips coated with 100 µg/ml ﬁbrinogen. HEK-
293T cells were allowed to adhere to glass coverslips prior to
calcium phosphate transfection with FLAG-tagged Tspan9, and
incubated for 24 h. Both megakaryocytes and HEK-293T cells
were ﬁxed and prepared for ﬂuorescence microscopy as described
previously [21]. The rabbit anti-Tspan9 antibody was used at a
concentration of 2 µg/ml. Images were acquired using a DMIRE2
Leica confocal microscope (Leica) with a 63× oil immersion 1.40
NA (numerical aperture) plan-apochromat oil immersion lens.
Images were captured using Leica Confocal Software and ofﬂine
analysis was performed with Adobe Photoshop.
Quantiﬁcation of tetraspanins in human platelets
Tetraspanins were quantiﬁed using six human donors: three males
of Caucasian, Chinese and Indian origin, and three females of
Arabic, Caucasian and Japanese origin. Washed platelets were Q1
prepared as previously described [22], but with the modiﬁcation
that platelets were taken from the top third of the platelet-rich
plasma to ensure that they were essentially free of other blood
cells.
The number of copies of CD9 per platelet cell surface was
determined using the anti-CD9 monoclonal antibody 1AA2 [15]
and the Platelet Calibrator Kit (Biocytex), according to the
manufacturer’s instructions. The relative expression levels of
Tspan9 compared with CD9, CD63 and CD151 in platelets were
determined using a quantitative Western blotting method that
we have used previously to quantify protein tyrosine kinases in
lymphocytes [23,24]. Reference samples of FLAG-tagged forms
of each tetraspanin were ﬁrst generated by transiently transfecting
each construct into HEK-293T cells using the calcium phosphate
protocol, lysing the cells two days later with 1%Nonidet P40 and
1% dodecylmaltoside lysis buffer (the latter to fully solubilize Q2
lipid rafts), immunoprecipitating with mouse anti-FLAG (M2)
agarose beads (Sigma), washing with stringent RIPA buffer to Q3
remove associated proteins, Western blotting under non-reducing
conditions with rabbit anti-FLAG (Sigma), and quantifying the
bands using ECL (enhanced chemiluminescence) in combination
with the GeneGnome quantitative Western blotting system
(Syngene). Speciﬁc FLAG-tetraspanin reference samples and
human platelet lysates, lysed as for theHEK-293T cells, were then
Western blotted under non-reducing conditions using tetraspanin-
speciﬁc antibodies (C9-BB for CD9, 6H1 for CD63, 11B1 for
CD151 and rabbit anti-Tspan9), and the bands were quantiﬁed
using the GeneGnome. Finally, the relative expression levels of
each tetraspanin were calculated by comparing the anti-FLAG
and anti-tetraspanin quantiﬁcation data, with the expression of
CD9 arbitrarily set to 100.
Platelet biotinylation and biochemical analyses
Washed human platelets were suspended at a concentration of
5× 108 per ml in PBS containing 1 mg/ml sulfo-NHS-SS-biotin
(Perbio) and gently rotated for 30 min at room temperature
(?? ◦C). The biotinylation reaction was quenched with 100 mM Q4
glycine in PBS, and the platelets pelleted and washed once
more with PBS. Platelets (5× 108) were lysed on ice in 1 ml
of either 1% Brij 97 (containing 1 mM CaCl2 and 1 mM MgCl2)
lysis buffer or 1% Triton X-100 lysis buffer (containing 1 mM
EDTA); both lysis buffers otherwise contained 10 mM Tris/HCl,
pH 7.5, 150 mM NaCl, 0.01% sodium azide, 200 µg/ml 4-(2-
aminoethyl)-benzenesulfonyl ﬂuoride hydrochloride, 10 µg/ml
aprotinin, 10 µg/ml leupeptin, 1 µg/ml pepstatin A, 10 µM NaF
and 2 mM sodium orthovanadate. Lysates were pre-cleared at
c© The Authors Journal compilation c© 2008 Biochemical Society
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4 ◦C for 30 min each with 10 µl Protein G sepharose (Sigma)
followed by addition of 10 µl Protein G sepharose pre-coupled
with 1 µg of eitherMOPCmouse or normal rabbit control Ig. Pre-
cleared lysates were immunoprecipitated at 4 ◦C for 90 minutes
with speciﬁc antibodies (1AA2 for CD9, 11B1 for CD151,
rabbit anti-Tspan9, 4F10 for α6 and Gi9 for α2), pre-coupled
to 10 µl Protein G sepharose, and washed four times with
lysis buffer on ice. Non-reducing samples were separated on 4–
12% gradient gels (Invitrogen) for blotting with IRDye 800CW-
conjugated streptavidin (LI-COR). The blots were visualized
using the Odyssey Infrared Imaging System (LI-COR).
Co-immunoprecipitations using non-biotinylated plateletswere
performed as described above, with the exception that Western
blots were visualized using Western Lightning chemilumin-
escence reagents (Perkin Elmer) and Hyperﬁlm (Amersham
Biosciences), which was developed using a Compact X4 ﬁlm
processor (Xograph Imaging Systems).
Cleavage of N-linked oligosaccharides from Tspan9 in vitro
was performed using PNGase F (peptide N-glycosidase F)
according to themanufacturer’s protocol (NewEnglandBioLabs).
RESULTS
Primary mouse megakaryocytes express mRNA for
19 tetraspanins
A total of 33 tetraspanins have been identiﬁed in the human
and mouse genomes, but only four have been identiﬁed as
platelet-expressed using speciﬁc antibodies, namely CD9, CD63,
CD151 and Tspan32 [9]. This is primarily due to a lack of
antibodies and to the technical difﬁculties in performing genomics
in the platelet [10]. To identify tetraspanins that are potentially
expressed in platelets, we examined mRNA expression in their
nucleated precursor cell, the megakaryocyte, through re-analysis
of our previously reported SAGE library [11]. SAGE provides
a quantitative measure of relative mRNA levels by essentially
converting each mRNA into a short piece of DNA, termed a
SAGE tag, which can be ligated with other tags and readily
sequenced [25]. SAGE identiﬁed 16 tetraspanins in primary
mouse megakaryocytes (Figure 1). The expression of each was
conﬁrmed by RT–PCR, which also identiﬁed an additional three
tetraspanins (CD82, Tspan5 and Tspan18) that fell below the
threshold of detection in our SAGE library (results not shown).
The most abundant tetraspanin was CD63, followed by CD9 and
CD151, each of which is known to be expressed in platelets.
The other platelet tetraspanin, Tspan32, was also relatively
highly expressed in megakaryocytes. Of the other 15 tetraspanins
identiﬁed, most have not been reported as megakaryocyte-
expressed and remain unstudied at the protein level.
Tspan9 mRNA is relatively speciﬁc to human megakaryocytes
versus other haematopoietic cells
Since SAGE is quantitative, different SAGE libraries can be
compared with each other to identify cell type-speciﬁc genes.
We have previously performed such comparisons to show that
the most megakaryocyte-speciﬁc genes tend to be important for
platelet function [11]. Similar analyses of tetraspanins, however,
revealed that none were speciﬁc to megakaryocytes (results not
shown), although the fact that nine of the tetraspanins had only
ﬁve tags or less made it difﬁcult to determine statistically whether
any of these were over-represented in megakaryocytes compared
with other cell types. To address this issue, we used our blood
cell expression atlas data [12] to compare tetraspanin mRNA
expression in megakaryocytes with seven other haematopoietic
Figure 1 Tetraspanin expression in primary mouse megakaryocytes
A LongSAGE library was generated from mouse megakaryocytes grown in vitro from bone
marrow precursors [11]. The bar chart shows the number of SAGE tags, for those tetraspanins
that were identiﬁed, out of 53046 total tags.
Figure 2 Tspan9 is relatively speciﬁc to human megakaryocytes when
compared with other haematopoietic cell types
Whole genome expression data was obtained for eight different human blood cells using Illumina
HumanWG-6 v2 Expression BeadChips. Mean normalized intensity values are shown, with error
bars representing S.E.M from either 4 or 7 replicates. The dashed line represents the cut-off for
present/absent.
cell types. The Illumina HumanWG-6 v2 Expression BeadChips,
used in this study, is a recently developed bead-based DNA
microarray that largely overcomes the problems of intra- and
inter-array reproducibility associated with earlier microarray
types [26]. Interestingly, the tetraspanins that were more highly
expressed inmegakaryocytes than other cell typeswere the known
platelet tetraspanins CD9, CD63, CD151 and Tspan32, as well
as Tspan4 and Tspan9 (Supplementary Figure 1, at http://www.
BiochemJ.org/bj/416/bj416ppppadd.htm). The most megakaryo-
cyte-speciﬁc of these was Tspan9 (Figure 2), a functionally
unstudied tetraspanin that was originally named NET-5 [27],
and which we and others had identiﬁed as a candidate platelet
tetraspanin using proteomic analyses of the human platelet surface
[11,28] and DNA microarray analyses of human megakaryocytes
[29]. Moreover, Tspan9 is remarkably highly conserved during
c© The Authors Journal compilation c© 2008 Biochemical Society
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evolution, with amino acid identities of 97% for human
compared with mouse and 91% for human compared with frog,
suggesting that this tetraspanin may be functionally important in
megakaryocyte and platelet biology.
Tspan9 protein is expressed in megakaryocytes and platelets
To determine whether Tspan9 is indeed a new platelet tetraspanin,
we generated the ﬁrst antibodies to this protein in the form
of rabbit and chicken polyclonal antisera to the C-terminal
cytoplasmic tail of Tspan9, a region that is identical in amino acid
sequence between human and mouse. The antisera were peptide-
puriﬁed and their efﬁcacy conﬁrmed by Western blotting lysates
of HEK-293T cells transiently transfected with mouse Tspan9
(Figure 3A). The multiple bands detected in the Western blot of
transfected Tspan9 are likely to represent immature glycoforms
that may be relatively abundant in an over-expression system.
Indeed, Tspan9 has a single predicted N-linked glycosylation
site, and treatment of Tspan9 immunoprecipitates with an N-
glycosidase reduced the banding pattern to a single species
(Figure 3B). Moreover, N-glycosidase treatment of Tspan9
immunoprecipitates from human platelet lysates conﬁrmed that
Tspan9 is a glycoprotein that is expressed in this cell type
(Figure 3B). Confocal microscopy analysis of Tspan9-transfected
cells, in which not all of the cells were positive due to the transient
nature of the transfection, suggested a predominantly plasma
membrane localization for Tspan9 (Figure 3C).
The Tspan9 antibody was used to Western blot whole cell lys-
ates of human platelets and a panel of haematopoietic cell lines
which had been normalized for protein content (Figure 3D).
Tspan9 was readily detected in platelets but not in the other
cell types, including the megakaryocyte-like cell lines DAMI and
MEG-01, suggesting that Tspan9 is predominantly restricted to
primary cells of this lineage (Figure 3D). Tspan9 was similarly
detected in mouse platelet lysates, as well as in lung, with
relatively weak expression in brain, kidney, liver and spleen
(Figure 3E). Bonemarrow, amajor site formegakaryocytopoiesis,
was positive upon longer exposure (results not shown), but its
weak signal was probably due to the relatively low numbers
of megakaryocytes in this tissue. Indeed, expression of Tspan9
protein in primary mouse megakaryocytes (Figure 3F), and the
proplatelet structures that they form (Figure 3G), was conﬁrmed
by ﬂuorescence microscopy, a technique that was used because
of difﬁculties in obtaining enough mature megakaryocytes for
Western blotting. Tspan9 staining throughout the megakaryocyte
suggests localization to the demarcationmembrane system, which
is an extensive network of membrane channels that is connected
to, and is thought to originate from, the plasma membrane [30].
Quantiﬁcation of tetraspanins in human platelets
Quantiﬁcation of Tspan9 expression levels on platelets may
provide clues as to potential binding partners, which may be
expressed at similar levels. The human platelet cell surface is
relatively well characterized with respect to copy numbers of
the major glycoproteins, but amongst tetraspanins only CD9 has
been quantiﬁed. Three different groups, using iodinated CD9
antibodies, reported 65000 [31], 46000 [32] and 38000 [33]
copies per platelet. To determine whether these discrepancies
were due to donor variation, we quantiﬁed CD9 levels on the
platelets of six donors, of diverse ethnic backgrounds, using a ﬂow
cytometry-based method that we have previously used to quantify
other platelet glycoproteins [34]. CD9 levelswere similar between
individuals, with a mean of 49000 copies per platelet, with a
S.D. of 3560 (Figure 4). This suggests that the 65000 to 38000
Figure 3 Generation of a new antibody identiﬁes the Tspan9 glycoprotein
as a novel megakaryocyte/platelet tetraspanin
(A) HEK-293T cells were transiently transfected with empty vector (−) or FLAG-tagged mouse
Tspan9 (+) and whole cell lysates were Western blotted with the peptide-puriﬁed rabbit
anti-Tspan9 antibody. Essentially identical data were generated with the chicken anti-Tspan9
antibody (results not shown). (B) FLAG-tagged mouse Tspan9, transiently transfected into
HEK-293T cells, and endogenous Tspan9 from human platelets, were immunoprecipitated with
rabbit anti-Tspan9 antibody and subjected to control (−) or N-glycosidase (+) treatment with the
enzyme PNGase F. Samples were analysed by Western blotting with chicken anti-Tspan9 anti-
body. (C) HEK-293T cells were transiently transfected with FLAG-tagged mouse Tspan9, ﬁxed,
permeabilized and analysed by ﬂuorescence confocal microscopy with the rabbit anti-Tspan9
antibody. The left panel identiﬁes the cells by DIC (differential interference contrast) microscopy
and the right panel is amid-plane confocal section showingTspan9expression in a subpopulation
of the cells. (D) Whole cell lysates of the human cell lines DG75 and Raji (B-cells),
HPB-ALL and Jurkat (T-cells), DAMI (megakaryocyte-like), HEL (erythroleukaemia) andMEG-01
(megakaryocyte-like), and human washed platelets were normalized for protein content and then
Western blotted with the rabbit anti-Tspan9 antibody. (E) Whole cell lysates of various mouse
tissues andwashedmouse platelets were normalized for protein content and thenWestern blotted
with the rabbit anti-Tspan9 antibody. In this panel and the previous panel, essentially identical
data were generated with the chicken anti-Tspan9 antibody (results not shown). (F) Mouse
megakaryocytes and (G) proplatelets were generated from cultured fetal liver cells, allowed to
spread on ﬁbrinogen, ﬁxed, permeabilized and analysed by ﬂuorescence confocal microscopy
with the rabbit anti-Tspan9 antibody. The left panel identiﬁes the cells by DIC and the right panel
shows Tspan9 staining. Control staining with normal rabbit immunoglobulin did not yield a
substantial signal (results not shown).
range in previously reported copy numbers [31–33] reﬂects differ-
ences in antibodies and methodology. Nevertheless, a copy
number of approx. 50000 ranks CD9 as a major component of
c© The Authors Journal compilation c© 2008 Biochemical Society
Tspan9 is a novel platelet tetraspanin 5
Figure 4 CD9 is expressed at 49000 surface copies per cell on human
platelets
The number of surface copies of CD9 per platelet was determined using the mouse IgG1
anti-CD9 monoclonal antibody 1AA2 and the Platelet Calibrator Kit from Biocytex. (A) The
calibrator beads, coated with the indicated numbers of mouse IgG1 antibody molecules,
were stained with FITC-conjugated anti-mouse antibody and analysed by ﬂow cytometry. (B)
Washed human platelets from a representative donor were stained with an IgG1 control or the
CD9 monoclonal antibody, followed by FITC-conjugated anti-mouse antibody and analysed
by ﬂow cytometry. (C) The geometric mean ﬂuorescence intensities from (A) and (B) were
compared, to quantify CD9 on human platelets. Data are shown for six donors of diverse ethnic
backgrounds.
the platelet cell surface, compared to the two other major glyco-
proteins, integrin αIIbβ3 (80000 copies) [35] and GPIb-IX-V
(25000) [36].
Quantiﬁcation of Tspan9 by the ﬂow cytometry-based method
is not readily applicable to intracellular epitopes, such as the C-
terminal cytoplasmic tail of Tspan9 to which our antibody was
raised. Therefore we quantiﬁed Tspan9 in human platelets relative
to CD9, and other tetraspanins, using a Western blotting protocol
with epitope-tagged standards, an approach we used previously
to quantify protein tyrosine kinases in lymphocytes [23,24].
The platelet lysates were made in a lysis buffer that included
dodecylmaltoside to fully solubilize lipid rafts, although Tspan9
and other platelet tetraspanins appear to be largely excluded from
lipid rafts (results not shown and [37]). Using the same six donors
as for the previous CD9 quantiﬁcation (Figure 4), we found
Tspan9 to be expressed at 6% of the level of CD9, with simi-
lar expression between donors (Figure 5). In comparison, CD151
was expressed at a 2.3-fold greater level than Tspan9, whereas
CD63 was 3-fold lower than Tspan9 (Figure 5). These results
suggest that the Tspan9 expression level, similar that of other
tetraspanins, is tightly regulated in human platelets, and can be
estimated at approximately 2800 surface copies, with a S.D. of
600, assuming the same cell surface to intracellular localization
ratio for CD9 and Tspan9.
Tspan9 is a component of tetraspanin microdomains
on human platelets
To determine whether Tspan9 is a component of tetraspanin
microdomains, Tspan9-associated cell surface proteins were
analysed following Tspan9 immunoprecipitation in two different
detergents, Brij 97 and Triton X-100. In the presence of calcium
and magnesium ions, 1% Brij 97 is a relatively weak detergent
that is known to largely maintain tetraspanin–tetraspanin inter-
actions. In contrast, the more stringent detergent 1% Triton
X-100 disrupts tetraspanin–tetraspanin interactions but maintains
certain tetraspanin–partner protein interactions [5,38].
As shown in Figure 6(A) (left panel), Tspan9 immunoprecipita-
tion fromBrij 97 lysates of surface biotinylated platelets contained
several proteins. Similar patterns of immunoprecipitated proteins
were observed in immunoprecipitations for CD9, CD151 and
the tetraspanin-associated laminin-binding integrin α6β1 [4]
(Figure 6A, left panel). Consistent with its relatively high
expression level, CD9 immunoprecipitation yielded more intense
bands. As a control, the collagen-binding α2β1 integrin, which is
not thought to be tetraspanin-associated [4], was predominantly
immunoprecipitated as a doublet corresponding to the molecular
weights of the integrin α2 and β1 chains (Figure 6A, left
panel). For each immunoprecipitation in TritonX-100 (Figure 6A,
upper right panel), the major bands were the immunoprecipitated
proteins themselves, with some weaker bands, presumably
representing relatively tightly associated proteins, detected on
a longer exposure (Figure 6A, lower right panel). For Tspan9,
the most prominent of these was a 43 kD protein (p43) that
was also present in CD151, but not CD9, immunoprecipitates
(Figure 6A, lower right panel). A 60 kDa protein (p60) was
also identiﬁed in Tspan9 and α6 immunoprecipitates (Figure 6A,
lower right panel), which corresponded to a major component of
tetraspaninmicrodomains observed inBrij 97 immunoprecipitates
(Figure 6A, left panel). These two proteins may represent novel
binding partners for Tspan9.
Since Tspan9 and other tetraspanins co-immunoprecipitate a
similar pattern of surface biotinylated proteins in Brij 97, this
suggests that Tspan9 is a component of tetraspaninmicrodomains.
To provide further supporting evidence for this idea, immuno-
precipitations from non-biotinylated platelets were blotted for
Tspan9 (Figure 6B, upper panels). In Brij 97, Tspan9 was
detected in CD9, CD151 and α6 immunoprecipitates, but not
in those for control antibody or α2, suggesting that Tspan9 is
tetraspanin-associated. These interactions were not observed in
more stringent Triton X-100 lysis conditions that are thought to
disrupt tetraspanin–tetraspanin interactions [5,38]. Interestingly,
Tspan9 was immunoprecipitated more efﬁciently in Triton X-100
than in Brij 97, despite similar solubilities in the two detergents
as shown by Western blotting of whole cell lysates (Figure 6B,
upper panels). This result is consistent with Figure 6(A), in which
a biotinylated 27 kDa protein band corresponding to Tspan9
was immunoprecipitated more efﬁciently in Triton X-100. These
ﬁndings suggest that the epitope for the Tspan9 antibody, which is
12 amino acids long, C-terminal and membrane-proximal, is less
accessible to an immunoprecipitating antibody in the context of
c© The Authors Journal compilation c© 2008 Biochemical Society
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Figure 5 Quantiﬁcation of Tspan9, CD63 and CD151, relative to CD9, in human platelets
(A) HEK-293T cells were transiently transfected with empty vector control, FLAG-tagged human CD9, CD63, CD151 or mouse Tspan9 (note that the Tspan9 antibody epitope is identical in
protein sequence between human and mouse). Mouse anti-FLAG immunoprecipitates were Western blotted with a rabbit anti-FLAG antibody and each tetraspanin quantiﬁed, following ECL
chemiluminescence, using the GeneGnome quantitative Western blotting system from Syngene. These FLAG–tetraspanin samples were then compared to whole cell lysates of washed human platelets
by Western blotting for (B) CD9, (C) CD63, (D) CD151 and (E) Tspan9 and the relative intensities quantiﬁed as in (A). (F) The data in (A–E), for platelets from six human donors of diverse ethnic
backgrounds, were used to quantify the relative expression levels of each tetraspanin in human platelets. The data are presented as mean relative expression levels+− S.D.
intact tetraspanin microdomains in Brij 97, perhaps due to steric
hindrance by other tetraspanins or associated proteins.
Tetraspanin microdomains on human platelets contain GPVI but
not GPIbα or αIIbβ3
The identities of most of the tetraspanin-associated platelet
proteins, observed in tetraspanin immunoprecipitations from
Brij 97 lysates (Figure 6A, left panel), are not known, but
their molecular weights suggest as candidates the major platelet
glycoproteins GPIbα (the von Willebrand receptor), αIIbβ3 (the
major platelet integrin) and GPVI (the main signalling receptor
for collagen). However, GPIbα and αIIb were not detected in
Western blots of tetraspanin immunoprecipitates (Figure 6B,
middle and lower panels), suggesting that these proteins are not
tetraspanin-associated. A similar experiment proved difﬁcult for
GPVI because in Western blots this protein was obscured by
the immunoglobulin heavy chain from the immunoprecipitating
antibodies (results not shown). To overcome this problem, GPVI
immunoprecipitates were analysed for tetraspanin-associated
proteins (Figure 6C) and tetraspanins themselves (Figure 6D).
GPVI immunoprecipitation from Brij 97 lysates of biotinylated
platelets yielded a strikingly similar pattern of biotinylated
proteins to CD151 immunoprecipitation (Figure 6C). In Triton X-
100, most of these interactions were lost, leaving a major 62 kD
band in GPVI immunoprecipitates and a major 27 kD band in
CD151 immunoprecipitates (Figure 6C), corresponding to the
molecular weights of GPVI and CD151, respectively. To conﬁrm
that GPVI was associated with tetraspanins in these immuno-
precipitation experiments, speciﬁc CD9 and CD151 blots were
performed (Figure 6D). In Brij 97 lysates, both tetraspanins
were detected in GPVI immunoprecipitates, but not in those for
control or α2 antibodies. These interactions were lost in Triton X-
100 lysates. The GPVI–tetraspanin interaction appeared to be less
robust than the positive control α6β1–tetraspanin interaction, the
latter of which was even detected in more stringent Triton X-100
lysates (Figure 6D), consistentwith the direct and relatively strong
nature of the CD151 interaction with this integrin [4]. Together
these data suggest that GPVI is a novel tetraspanin-associated
protein.
DISCUSSION
In the present study, we found 19 tetraspanins to be expressed in
megakaryocytes and raised the ﬁrst antibodies to the previously
uncharacterized tetraspanin Tspan9, which was originally named
NET-5 [27]. Tspan9 protein expression was relatively speciﬁc to
platelets when compared to other blood cell types. Moreover,
biochemical analyses demonstrated that Tspan9 was a novel
component of tetraspanin microdomains on the platelet surface.
This is the ﬁrst characterization of the tetraspanin Tspan9 at
the protein level through the generation of antibodies. Of the 33
c© The Authors Journal compilation c© 2008 Biochemical Society
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Figure 6 Tspan9 is a component of platelet tetraspanin microdomains that include GPVI and α6β1, but not αIIbβ3, α2β1 or GPIbα
(A) Human washed platelets were surface biotinylated, lysed in 1% Brij 97 (left panel) or more stringent 1% Triton X-100 (right panels, including a longer exposure), immunoprecipitated with the
indicated antibodies and the biotinylated proteins were detected by Western blotting with streptavidin using the Odyssey Infrared Imaging System from LI-COR. The position of certain proteins is
indicated by arrows. These results are representative of four experiments using different donors. (B) Immunoprecipitations were performed as described in (A), with the exception that non-biotinylated
platelets were used, that Western blotting was performed with Tspan9, GPIbα and αIIβ antibodies, and that blots were visualized using ECL and ﬁlm. (C) CD151 and GPVI immunoprecipitations
were performed from 1% Brij 97 (B) or 1% Triton X-100 (T) lysates of biotinylated platelets. Biotinylated proteins were detected by Western blotting with streptavidin and visualized using
chemiluminescence and ﬁlm. The dividing line indicates that images were grouped from two parts of the same gel. (D) GPVI, α2 and α6 immunoprecipitations were Western blotted with CD9 and
CD151 antibodies as described in (B).
tetraspanins in the human genome, antibodies have been reported
for less than half. As such, we do not know the full complement
of tetraspanins that are expressed in a given cell type and which
other proteins are recruited to tetraspanin microdomains. The pro-
bable reasons for the lack of antibody reagents are ﬁrstly the
relatively small size of tetraspanins and their association with
larger proteins in tetraspanin microdomains [39]. This may render
them virtually inaccessible to antibody recognition in the context
of intact cells, which are the predominant immunogens used to
date for the generation of tetraspanin monoclonal antibodies.
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Secondly, tetraspanin protein sequences are highly conserved
during evolution [40], so the number of tetraspanin non-self
epitopes is very low. However, we managed to overcome these
problems by raising antibodies in rabbit and chicken to the
intracellular C-terminal tail of human Tspan9. Although this
approach was successful for Tspan9, it is not applicable to all
tetraspanins, since some have cytoplasmic tails that are predicted
to contain as few as four amino acids and are therefore too short to
be used as immunogens. Moreover, we have failed to raise good
antibodies to Tspan3, Tspan15, Tspan17, Tspan32 and Tspan33
using this method, although an antibody that recognized both
Tspan13 and Tspan31 was successfully generated (M.B.P. and
M.G.T., unpublished work).
In order to identify platelet tetraspanins in the absence of
antibodies, we measured mRNA levels in megakaryocytes, the
platelet progenitor cells, since platelets have extremely low
levels of mRNA [10]. To do this, we took advantage of a
mouse megakaryocyte SAGE library that we had generated
previously [11], and more recent DNA microarray analyses of
humanmegakaryocytes and seven other haematopoietic cell types
[12]. SAGE, which detects essentially all expressed genes in
a quantitative manner, identiﬁed the four platelet tetraspanins,
CD63, CD9, CD151 and Tspan32, amongst the six most highly
expressed mouse megakaryocyte tetraspanins. We identiﬁed an
additional 15 tetraspanins, at generally lower expression levels,
most of which have not been reported on megakaryocytes or
platelets [9], but which nevertheless may have important roles in,
for example, the regulation of G protein-coupled receptors that
are expressed at relatively low levels. A total of 19 tetraspanins
in megakaryocytes may be typical for other cell types. For
example, a ﬁgure of 20 tetraspanins has been estimated for
leukocytes [41], and we have found 22 for endothelial cells upon
analyses of 11 publicly-available SAGE libraries (J.H., R.B. and
M.G.T., unpublished data). Unlike SAGE, the microarray data
is not a reliable indicator of relative tetraspanin expression in
megakaryocytes, due to the potential for differential hybridization
efﬁciencies for different genes. However, the microarrays do
enable a comparison of the expression levels of individual
tetraspanins between different cell types. Those tetraspanins
that have been reported to be expressed in human platelets
using antibodies (CD9, CD63, CD151 and Tspan32) [9], or by
mass spectrometry peptide sequencing (Tspan9, Tspan15 and
Tspan33) [11,28], were relatively highly represented in human
megakaryocytes. In contrast, a number of tetraspanins were not
detected by either SAGE or DNA microarray, for example the
CD9-related Tspan2 and the CD151-related Tspan11, suggesting
that they are not expressed by the megakaryocyte/platelet lineage
and thus do not compensate for CD9 and CD151 when these
genes are knocked out in platelets. Finally, CD37, CD81 and
Tspan4 were identiﬁed at the mRNA level in megakaryocytes but
are absent at the protein level from human platelets (results not
shown). It is possible that these tetraspanins are also not expressed
at the protein level in megakaryocytes. Alternatively they may
be megakaryocyte-expressed but actively excluded from platelets
during platelet formation.
Genomic approaches, such as SAGE and DNA microarrays,
do not prove expression at the protein level. However, using
our new antibodies to Tspan9, we conﬁrmed its expression on
megakaryocytes and platelets by immunoﬂuorescence micro-
scopy, Western blotting and immunoprecipitation from surface-
biotinylated cells. Consistent with its relative mRNA speciﬁcity
for megakaryocytes within the haematopoietic lineage, Tspan9
was not readily detected in human B- and T-cell lines, or mouse
thymus, and only weakly in spleen. Tspan9 was only detected
in primary megakaryocytes and proplatelets, and not human
megakaryocyte-like cell lines, highlighting that these cells are not
good models for primary cells. Tspan9 is not entirely restricted
to megakaryocytes and platelets, though, since expression was
also detected in mouse lung, brain and kidney. In human platelets,
we found that Tspan9 expression was tightly regulated between
donors at a level of 6% of CD9, 43% of CD151 and three times
the level of CD63 (this relatively low protein expression level
for the latter in platelets contrasts with its high mRNA expression
inmegakaryocytes, for reasons that are currently unknown). Since
we also showed that CD9 is the major platelet tetraspanin at
49000 cell surface copies per cell, we can estimate a Tspan9
copy number of approximately 2800 on the platelet surface,
assuming that the plasma membrane to intracellular ratio is the
same for each protein. Therefore it seems unlikely that the major
platelet glycoproteins, such as integrin αIIbβ3 (80000 copies)
[35] or GPIb-IX-V (25000 copies) [36], would be direct binding
partners for Tspan9. We did detect 43 and 60 kDa proteins in
relatively stringent co-immunoprecipitations with Tspan9, and
we are working to identify these proteins using proteomics.
Immunoprecipitation of tetraspanins CD9, CD151 and Tspan9,
and the CD151-associated integrin, α6β1, from surface bio-
tinylated platelets revealed a distinct pattern of proteins in the
relatively weak detergent Brij 97, in which tetraspanin microdo-
mains are thought to remain largely intact [5,38]. These proteins
are likely to represent the major components of tetraspanin
microdomains on the platelet cell surface. Using speciﬁc anti-
bodies, we found that these tetraspanin-associated proteins do
not include three of the major platelet glycoproteins, namely
GPIb-IX-V, α2β1 or αIIbβ3. The latter result was somewhat
surprising, since αIIbβ3 was reported to co-immunoprecipitate
with CD151 inHEL cells lysed in themild detergent CHAPS [42],
and with CD151 and Tspan32 in mouse platelets lysed in Triton
X-100 [7,8]. However, we did identify GPVI as a novel com-
ponent of tetraspanin microdomains using co-immunoprecipit-
ation experiments with CD9 and CD151 in Brij 97. GPVI
interaction with CD9 and CD151 was lost in more stringent
Triton X-100 detergent, which does not preserve tetraspanin–
tetraspanin interactions and hence microdomain integrity [5,38].
This suggests that either the GPVI-tetraspanin interaction is
relatively weak or that GPVI interacts more strongly with an
unidentiﬁed tetraspanin. If the latter is true, Tspan9 is unlikely
to be the direct binding partner for GPVI because we could not
detect Tspan9 in GPVI immunoprecipitates (results not shown).
The functional consequences of GPVI-tetraspanin association are
currently unknown. Interestingly, the antigen receptors on B-
and T-lymphocytes, which signal via an ITAM (immunoreceptor
tyrosine-based activation motif)-based mechanism in common
with the GPVI/FcRγ complex [43], are dependent on tetraspanins
for their normal function [44–48]. Particularly well characterized
is the role of the tetraspanin CD81 on B-cells, where it interacts
with the CD19 glycoprotein. CD19 is a signallingmolecule which
forms a complex with the complement receptor CD21, and is
recruited to the B-cell receptor complex upon its engagement
by complement-opsonized antigen. In the absence of CD81, the
activated B cell receptor fails to localize correctly to lipid raft
microdomains and fails to induce sustained signalling [44,45].
Moreover, CD19 biosynthetic maturation and trafﬁcking to the
plasma membrane are impaired [49]. Our future studies will aim
to determine whether a speciﬁc platelet tetraspanin can similarly
regulate GPVI maturation, trafﬁcking and/or signal transduc-
tion.
In summary, we have shown that Tspan9 is relatively highly
expressed in the megakaryocyte/platelet lineage and is a com-
ponent of tetraspanin microdomains on the platelet surface.
Tspan9 is remarkably highly conserved during evolution, even
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relative to most other tetraspanins. A feature of conserved amino
acids is their involvement in intra-molecular or inter-molecular
interactions [50]. This raises the possibility that almost the entire
surface of Tspan9 is engaged in protein–protein interactions.
Indeed, we hypothesize that Tspan9 has multiple simultaneous
interacting partners and functions as an interaction ‘hub’ within
tetraspanin microdomains. Tspan9 may therefore be essential for
microdomain organization and for the function of microdomain-
associated proteins on the platelet surface. The generation of
Tspan9-deﬁcient mice is in progress to test this hypothesis.
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Identiﬁcation of Tspan9 as a novel platelet tetraspanin and the collagen
receptor GPVI as a component of tetraspanin microdomains
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Figure S1 DNA microarray analyses of the 33 human tetraspanins in primary haematopoietic cells
Experiments using Illumina Human WG-6 v2 Expression BeadChips were performed using mRNA from eight different human cell types from four to seven donors. Normalized intensity values (Log2)
for each tetraspanin are presented as a heat map, with white panels representing no expression and black panels representing the highest expression level.
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